Latest in Cardiology from ACC.org

• Transcatheter Aortic Valve Implantation: Durability and Management of Valve Failure
  Transcatheter aortic valve implantation (TAVI) has become a cornerstone therapy for patients with severe aortic stenosis across a wide spectrum of clinical presentations and surgical risk. Initially reserved for patients at prohibitive or high surgical risk, TAVI is now widely adopted in populations at intermediate and low risk...
• ACC Leadership Update: Reflections and Highlights From the March BOT Meeting at ACC.26
  I am truly honored to serve as the new president of the ACC. I am excited to work alongside all of you over the coming year as we advance the College’s strategic priorities and continue our shared Mission to transform cardiovascular care for all.
• ACC Practice Made Perfect: The Dyad Leadership Model - Foundations for Success
  In this kickoff episode sponsored by the CV Management Section, we explore what truly makes a dyad partnership effective in cardiovascular care.
• Clinical Practice Algorithm For the Follow-Up of Unrepaired and Repaired Tetralogy of Fallot
  Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease (CHD). Early management of this condition is typically dictated by the degree of pulmonary stenosis (PS) and resulting oxygen saturations.
• Addressing Modifiable Barriers May Improve Access to Quadruple GDMT For Veterans With HFrEF
  Addressing modifiable barriers such as medication copays may improve access to care and outcomes for patients with heart failure with reduced ejection fraction (HFrEF), according to a cohort study published April 1 in JAMA Cardiology, which identified significant gaps in the rate and timeliness of quadruple therapy for veterans who are newly diagnosed.